Abstract
AimTo screen for the antibacterial activity of ent-kaurenoic acid (1) from the dichloromethane extract of Smallanthus sonchifolius leaves against Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, Escherichia coli, Enterobacter aerogenes, Klebsiella pneumoniae, and Pseudomonas aeruginosa, and for its antifungal activity against Candida albicans, Trichophyton rubrum, and Epidermophyton floccosum. MethodsCompound 1 was isolated by silica gel chromatography and its structure was elucidated by NMR spectroscopy. For assaying the antibacterial and antifungal activities of 1, the disk diffusion method was used, while the minimum inhibitory concentrations (MICs) were determined by the broth dilution method. ResultsWith the disk diffusion method, 1 was found to be active against all the Gram-positive organisms tested (S. aureus, S. epidermidis, B. subtilis) at the lowest concentration of 1 000 μg·mL−1, while it was active against the fungus T. rubrum at 10 000 μg·mL−1. No inhibitory activity was observed against C. albicans, E. floccosum and all the Gram-negative test strains. The activity indices (AI) of 1 were noted to be highest against S. aureus and lowest against T. rubrum. Statistically significant differences were found between the mean inhibition zones (IZ) of 1 and the standard drugs (ofloxacin and clotrimazole). The results of the broth dilution MIC determination revealed that 1 exhibited moderate activity against S. aureus and S. epidermidis with MIC values of 125 μg·mL−1 and 250 μg·mL−1, respectively; and weak activity against B. subtilis with a MIC of 1 000 μg·mL−1. The growth of T. rubrum in the MIC assay was not inhibited at the highest tested concentration of 1 (10 000 μg·mL−1). ConclusionThe minimum bactericidal concentration (MBC) indicated that the bactericidal activities of 1 occurred at concentrations higher than its growth inhibitory concentrations. Furthermore, the MBC: MIC ratio of 2:1 clearly demonstrated the in vitro bactericidal effect of 1 against S. aureus and S. epidermidis.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
